[an error occurred while processing this directive] | ����Ƥ���Բ�ѧ��־ 2004, 30(6) 390-392 DOI: ISSN: 2096-5540 CN: 32-1880/R | ||||||||||||||||||||||||||||||||||||||||||||||
����Ŀ¼ | ����Ŀ¼ | ������� | ������ [��ӡ��ҳ] [�ر�] | |||||||||||||||||||||||||||||||||||||||||||||||
���� |
| ||||||||||||||||||||||||||||||||||||||||||||||
���ɾ����Ŀ���ɸѡ��ԭģ���λ���о���չ | |||||||||||||||||||||||||||||||||||||||||||||||
����Ⱥ, ֣�� | |||||||||||||||||||||||||||||||||||||||||||||||
�Ϻ��ڶ�ҽ�ƴ�ѧ�������ҽԺƤ���� 200025 | |||||||||||||||||||||||||||||||||||||||||||||||
ժҪ��
�ֹ�����Ҫ�Ŀ��嶼����ʶ��ԭ�Ĺ����λ,���ɾ����Ŀ⼼������Ӧ��ǰ�����ǿ��Եõ�ģ�⿹ԭ��λ�ṹ�ͻ�ѧ������С�ķ���,ͨ����Щģ���λ��������Ѱ�ҡ�����Ѫ���е����쿹��,�����о������IJ����뷢�������Լ������Ե���ϼ���;���һ����������ԭ�յ��������,�ﵽ���Ƽ�����Ŀ��;ͬʱҲΪ��ҩ�Ŀ����ṩ����˼·�� | |||||||||||||||||||||||||||||||||||||||||||||||
�ؼ����� �Ŀ� ��ԭ ����ģ�� | |||||||||||||||||||||||||||||||||||||||||||||||
Abstract: | |||||||||||||||||||||||||||||||||||||||||||||||
Keywords: | |||||||||||||||||||||||||||||||||||||||||||||||
�ո����� 2004-02-03 ������ ����淢������ | |||||||||||||||||||||||||||||||||||||||||||||||
DOI: | |||||||||||||||||||||||||||||||||||||||||||||||
������Ŀ:
������Ȼ��ѧ�����������(30170858) | |||||||||||||||||||||||||||||||||||||||||||||||
ͨѶ����: | |||||||||||||||||||||||||||||||||||||||||||||||
�����: | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
�ο����ף� | |||||||||||||||||||||||||||||||||||||||||||||||
[1] Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science, 1985, 228:1315-1317. [2] Felici F, Castagnoli L, Musacchio A, et al. Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J Mol Biol, 1991, 222:301-310. [3] Ferrieres G, Villard S, Pugniere M, et al. Affinity for the cognate monoclonal antibody of synthetic peptides derived from selection by phage display. Role of sequences flanking thebinding motif. Eur J Biochem, 2000, 267:1819-1829. [4] Ganglberger E, Grunberger K, Sponer B, et al. Allergen mimotopes for 3-dimensional epitope search and induction of antibodies inhibiting human IgE. FASEB J, 2000, 14:2177-2184. [5] Zhang WY, Wan Y, Li DG, et al. A mimotope of pre-S2 region of surface antigen of viral hepatitis B screened by phage display. Cell Res, 2001, 11:203-208. [6] Prezzi C, Nuzzo M, Meola A, et al. Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. J Immunol, 1996, 156:4504-4513. [7] Shibata R, Igarashi T, Haigwood N, et al. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat Med, 1999, 5:204-210. [8] Mascola JR, Stiegler G, VanCott TC, et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med, 2000, 6:207-210. [9] Baba TW, Liska V, Hofmann-Lehmann R, et al. Human neutralizing monoclonal antibodies of the IgGl subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med, 2000, 6:200-206. [10] Chen X, Scala G, Quinto I, et al. Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes. Nat Med, 2001, 7:1225-1231. [11] Xie S, Luca M, Huang S, et al. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.Cancer Res, 1997, 57:2295-2303. [12] Satyamoorthy K, Muyrers J, Meier F, et al. Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication. Oncogene, 2001, 20:4676. [13] Hafner C, Samwald U, Wagner S, et al. Selection of mimotopes of the cell surface adhesion molecule Mel-CAM from a random pV-28aa phage peptide library. J Invest Dermatol, 2002, 119:865-869. [14] Hobby P, Gardas A, Radomski R, et al. Identification of an immunodominant region recognized by human autoantibodies in a three-dimensional model of thyroid peroxidase. Endocrinology, 2000, 141:2018-2026. [15] Guo J, McLachlan SM, Rapoport B. Localization of the thyroid peroxidase autoantibody immunodominant region to a junctional region containing portions of the domains homologous to complement control protein and myeloperoxidase. J Biol Chem, 2002, 277:40189-40195. [16] Guo J, Yan XM, McLachlan SM,et al. Search for the autoantibody immunodominant region on thyroid peroxidase: epitopic footprinting with a human monoclonal autoantibody locates a facet on the native artigen containing a highly conformational epitope. J Immunol, 2001,166:1327-1333. [17] Bresson D, Cerutti M, Devauchelle G, et al. Localization of the discontinuous immunodominant region recognized by human anti-thyroperoxidase autoantibodies in autoimmune thyroid diseases. J Biol Chem, 2003, 278:9560-9569. [18] Myers MA, Davies JM, Tong JC, et al. Conformational epitopes on the diabetes autoantigen GAD65 identified by peptide phage display and molecular modeling. J Immunol, 2000, 165:3830-3838. [19] Mackay IR, Davies JM, Rowley MJ. Towards the pathogenesis of autoimmune liver disease. J Autoimmun, 1999, 13:163-169. |
|||||||||||||||||||||||||||||||||||||||||||||||
������������� | |||||||||||||||||||||||||||||||||||||||||||||||
�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���ص�����!�������ݲ�����վ�۵�.) | |||||||||||||||||||||||||||||||||||||||||||||||
Copyright 2008 by ����Ƥ���Բ�ѧ��־ |